Cambrian Biopharma Inc. Wiki, Company Profile, Logo, Founder, Net Worth, CEO, Pipeline, Biotechnology Research and more
Cambrian Biopharma Inc. operates as a biotech company. The company focuses on building medicines that will modernize healthcare in the 21st century, and therapeutics to lengthen the health span of the period of life spent in good health. Cambrian Biopharma serves clients worldwide.
Cambrian is advancing multiple scientific breakthroughs as a distributed development company, each targeting a biological driver of aging. The company’s approach is to develop interventions that treat specific diseases first, then deploy them as preventive medicines to improve quality of life/overall quality of life as we age.
|Company Name||Cambrian Biopharma|
|Date of Establishment||2019|
|Establishment Place||New York, New York|
|Founder||Christian Angermayer |
|Registered Address||New York, New York 11217, US|
|Telephone no.||Data not available|
|Data not available|
- Cambrian Biopharma was incorporated on 9th September, 2019 by James Peyer, a Ph.D. in stem cell biology and former co-founder and managing partner at health-focused venture capital firm Apollo Ventures along with billionaire investor and entrepreneur Christian Angermayer.
- The company has its headquarters in New York. Cambrian’s scientists and company building experts closely partner with pipeline company (PipeCo) teams offering scientific and organizational insights and support for a significant edge in a complex, rapidly evolving field.
- Cambrian’s sourcing and development engine allow us to identify promising science, deploy capital and teams of drug development experts, and provide stewardship to advance new medicines that will lengthen the lifespan of a human.
- Sensei Biotherapeutics
- Tornado Therapeutics
- Vita Therapeutics
A multifaceted approach is there to expand lifespan. By building new medicines that target the mechanisms underlying disease. We can treat damage at the molecular level long before symptoms manifest. Our cell consists of DNA, RNA, Proteins, fats, other small molecules Cells must remain healthy and functional to contribute to the overarching function of a tissue. As we age, whole networks of cellular processes can stop functioning. Cambrian scientists are targeting ‘’the nine hallmarks of aging’’. The company’s business model is to identify and invest in new discoveries from universities or other labs that target different causes or potential causes of aging.
Cambrian Biopharma is a multiasset longevity biotechnology company. As of 2021, Cambrian was focusing on three categories of aging- intracellular dysfunction, cellular dysfunction, and tissue level dysfunction. Its research includes muscle stem cell treatments for a rare form of childhood muscular dystrophy cancer.
If you want to know anything else about Cambrian Biopharma. Please comment below we will try to provide information.